mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Linde Schoenmaker; Dominik Witzigmann; Jayesh A. Kulkarni; Rein Verbeke; Gideon Kersten; Wim Jiskoot; Daan J.A. Crommelin

doi:10.1016/j.ijpharm.2021.120586

Keywords

Messenger RNAChemistryBiochemistryGene

Affiliated Institutions

Related Publications

Lipid nanoparticles for mRNA delivery

Xucheng Hou , Tal Zaks , Róbert Langer +1 more

Messenger RNA (mRNA) has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable deli...

2021 Nature Reviews Materials 2944 citations

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Rumiana Tenchov , Robert E. Bird , Allison Curtze +1 more

Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital compon...

2021 ACS Nano 1799 citations

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai , Lei He , Xiujuan Zhang +5 more

Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, calling for the development of safe and effective prophylactics ...

2020 Cellular and Molecular Immunology 1789 citations

SARS-CoV-2 vaccines in development

Florian Krammer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Kathryn E. Foulds , Joseph R. Francica , Seyhan Boyoglu-Barnum +71 more

Vaccination of nonhuman primates with mRNA-1273 induced robust SARS-CoV-2 neutralizing activity, rapid protection in the upper and lower airways, and no pathologic changes in th...

2020 New England Journal of Medicine 1134 citations

Publication Info

Year: 2021
Type: review
Volume: 601
Pages: 120586-120586
Citations: 1293
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1293

OpenAlex

Cite This

APA Style

                            
                                    Linde Schoenmaker, 
                                
                                    Dominik Witzigmann, 
                                
                                    Jayesh A. Kulkarni
                                
                                et al.
                            
                            (2021). 
                            mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. 
                            International Journal of Pharmaceutics
                            , 601
                            
                            , 120586-120586.
                            https://doi.org/10.1016/j.ijpharm.2021.120586

Identifiers

DOI: 10.1016/j.ijpharm.2021.120586